Boston Scientific Corporation vs Banco Santander SA — how do they compare? Boston Scientific Corporation trades at $51.05 (market cap $74.19B), while Banco Santander SA trades at $14.88 (market cap $211.63B). The key difference: Banco Santander SA is far larger — about 2.9× Boston Scientific Corporation's market cap, and Banco Santander SA pays a 1.89% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | SAN | |
|---|---|---|
Market Cap | $74.19B | $211.63B |
Sector | Health | Financials |
52-Week High | $108.14 | $14.71 |
52-Week Low | $42.63 | $9.37 |
Enterprise Value | $86.27B | — |
Dividend Yield | — | 1.89% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →